Breakthrough T1D Publishes Global Screening Guidance
New York, New York, U.S., September 10, 2026 Breakthrough T1D has announced the publication of new international consensus guidance...
biopharma
Advertisement
Avance Clinical Wins Australia-Taiwan Business Award
Taipei, Taiwan, September 11, 2026 Avance Clinical has received the Australia-Taiwan Business Excellence Award from the Australia New Zealand...
Definium Therapeutics to Present Phase 3 DT120 Data at Psych Congress
NEW YORK — September 10, 2026 Definium Therapeutics, Inc. announced plans to present six posters and an invited oral...
Epicyt Pharma Advances BAFA Toward Phase 2b Development
GOTHENBURG, Sweden — September 8, 2026 Epicyt Pharma AB reported positive topline results from its Phase 1/2a first-in-human study...
DelveInsight: CABP Market Set for Growth Through 2036
Las Vegas, Nevada, USA, September 7, 2026 The community-acquired bacterial pneumonia (CABP) treatment market is expected to expand through...
Advertisements
FDA Acts to Protect Access to Newborn Nutrition Products
Silver Spring, Maryland, USA, September 5, 2026 The U.S. Food and Drug Administration (FDA) has announced steps intended to...
Vertex Completes Crinetics Acquisition in $10 Billion Deal
Boston, Massachusetts, USA, September 1, 2026 Vertex Pharmaceuticals Incorporated has completed its acquisition of Crinetics Pharmaceuticals, Inc., strengthening its...
Ascletis Joins Hong Kong Stock Connect Programs
Hong Kong, September 7, 2026 Ascletis Pharma Inc. has announced that its ordinary shares have been included as eligible...
Climb Bio Phase 1 Data Support CLYM116 Q12W Dosing in IgA Nephropathy
Wellesley Hills, Mass., September 3, 2026 Climb Bio announced positive initial Phase 1 clinical data for CLYM116, its investigational...
Nxera Pharma to Receive $8.6M Milestone Payment from Centessa for OX2R Development
Tokyo, Japan and Cambridge, UK, September 3, 2026 Nxera Pharma announced that Centessa Pharmaceuticals, a wholly owned subsidiary of...
Advertisement
